Suppr超能文献

系统评价和随机对照试验的荟萃分析,评估大蒜补充剂对血清脂联素和瘦素水平的影响。

Systematic review and meta-analysis of randomised, controlled trials on the effects of garlic supplementation on serum adiponectin and leptin levels.

机构信息

Department of General Courses, School of Management and Medical Information Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.

Department of Nutrition, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

出版信息

Int J Clin Pract. 2021 Oct;75(10):e14200. doi: 10.1111/ijcp.14200. Epub 2021 May 2.

Abstract

BACKGROUND

Our aim in this meta-analysis was to determine the effect of garlic supplementation on adiponectin and leptin serum levels.

METHOD

A systematic search was conducted using PubMed, Scopus, ISI Web of Science and Cochrane Library for eligible trials up to November 2020. A fixed-effects model was used to pool calculated effect sizes.

RESULTS

Five trials were included in the overall analysis. Our analysis showed that garlic supplementation did not significantly affect adiponectin (Hedges's: 0.20; 95% CI: -0.06, 0.47; P-values = .12) and leptin (Hedges's: 0.08; 95% CI: -0.26, 0.41; P-values = .65) concentrations in comparison with placebo. However, in the subgroup analysis, significantly increased serum adiponectin level was seen following garlic supplementation in trials with a mean age of participants ˂30 years (Hedges's: 0.44; 95% CI: 0.01, 0.87; P-values = .04), the doses ˂1.5 g/d (Hedges's: 0.38; 95% CI: 0.02, 0.71; P-values = .04) and trials with duration ≥8 weeks (Hedges's: 0.48; 95% CI: 0.08, 0.89; P-values = .02).

CONCLUSION

Overall, garlic supplementation could not change the circulatory adiponectin and leptin levels. Subgroup analyses showed a significant reduction in adiponectin levels in younger participants, longer duration and lower intervention dose. However, further studies are needed to confirm the present results.

摘要

背景

本荟萃分析旨在确定大蒜补充剂对脂联素和瘦素血清水平的影响。

方法

我们对 PubMed、Scopus、ISI Web of Science 和 Cochrane Library 进行了系统检索,以获取截至 2020 年 11 月的合格试验。使用固定效应模型来汇总计算的效应量。

结果

共有 5 项试验纳入了总体分析。我们的分析表明,与安慰剂相比,大蒜补充剂对脂联素(Hedges's:0.20;95% CI:-0.06,0.47;P 值=0.12)和瘦素(Hedges's:0.08;95% CI:-0.26,0.41;P 值=0.65)浓度没有显著影响。然而,在亚组分析中,在参与者平均年龄<30 岁的试验中,大蒜补充剂后血清脂联素水平显著升高(Hedges's:0.44;95% CI:0.01,0.87;P 值=0.04)、剂量<1.5 g/d(Hedges's:0.38;95% CI:0.02,0.71;P 值=0.04)和持续时间≥8 周的试验(Hedges's:0.48;95% CI:0.08,0.89;P 值=0.02)。

结论

总体而言,大蒜补充剂不能改变循环脂联素和瘦素水平。亚组分析显示,在年轻参与者、持续时间更长和干预剂量更低的情况下,脂联素水平显著降低。然而,需要进一步的研究来证实目前的结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验